Burn clinical trials

Explore recruiting burn clinical trials.

Recruiting burn studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Burn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre, single-arm, open-label phase II trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered collagen-based skin graft composed of autologous fibroblasts and keratinocytes, for the treatment of patients with deep partial and full-thickness burns

Netherlands, Italy, Belgium, France, Portugal, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Tranexamic acid during excisional burn surgery

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial

Belgium, Germany, France, Italy, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

A2B-trial Antibioprophylaxis for excision-graft surgery in burn patient : a multicenter randomized double-bling study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Scar Remodeling after Burn Injury using Adipose-derived Allogeneic Stem Cells (ScarASC)

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Burn trials by city

Burn in Toronto Burn in Vancouver Burn in Montreal Burn in Calgary Burn in Edmonton Burn in Ottawa Burn in Winnipeg Burn in Quebec City Burn in Hamilton Burn in Kitchener Burn in London Burn in Halifax Burn in New York Burn in Los Angeles Burn in Chicago Burn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease